Meyka Pro banner
SI-BONE, Inc.

SI-BONE, Inc. (SIBN) Stock Overview

Explore SI-BONE, Inc.’s financial performance, market position, analyst ratings, and future outlook.

SIBNNASDAQ
HealthcareMedical - Devices
$18.95
$0.05(0.26%)
U.S. Market opens in 3h 2m

SI-BONE, Inc. (SIBN)

Meyka AI Score

Z

Key Financials

Market Cap840.4M
P/E Ratio-55.59
EPS (TTM)$-0.34
ROE-0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$19.47
3 Months$14.17
1 Year Target$14.81

SIBN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of SI-BONE, Inc. (NASDAQ: SIBN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, SI-BONE, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of SIBN on the NASDAQ shows an RSI of 64.52, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $14.81 for the NASDAQ listing.

Key metrics behind SI-BONE, Inc.'s NASDAQ-traded stock include a P/E ratio of -55.59 and a market capitalization of 840.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of SIBN on the NASDAQ.

Price Performance (NASDAQ: SIBN)

1-Day Change
-0.26%
5-Day Change
4.70%
1-Month Change
6.16%
3-Month Change
33.83%
6-Month Change
23.61%
Year-to-Date (YTD) Change
-3.90%
1-Year Change
20.70%
3-Year Change
-11.03%
5-Year Change
-9.72%
All-Time (Max) Change
-5.53%

Contact Information

408 207 0700
471 El Camino Real, Santa Clara, CA, 95050

Company Facts

3,760 Employees
IPO DateOct 17, 2018
CountryUS
Actively Trading

Frequently Asked Questions